APA (7th ed.) Citation

MA, F., V, H., V, B., SK, A., K, H., L, W., . . . JW, H. (2026). Gastric and rectal administration of encorafenib with targeted chemotherapy against BRAF V600E-mutant rectal cancer with bowel obstruction. The oncologist, 31(5), . https://doi.org/10.1093/oncolo/oyag103

Chicago Style (17th ed.) Citation

MA, Funk, et al. "Gastric and Rectal Administration of Encorafenib with Targeted Chemotherapy Against BRAF V600E-mutant Rectal Cancer with Bowel Obstruction." The Oncologist 31, no. 5 (2026). https://doi.org/10.1093/oncolo/oyag103.

MLA (9th ed.) Citation

MA, Funk, et al. "Gastric and Rectal Administration of Encorafenib with Targeted Chemotherapy Against BRAF V600E-mutant Rectal Cancer with Bowel Obstruction." The Oncologist, vol. 31, no. 5, 2026, https://doi.org/10.1093/oncolo/oyag103.